SG
Swarthmore Group’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | $311K | Sell |
644
-13,881
| -96% | -$6.7M | 0.13% | 23 |
|
2022
Q1 | $7.14M | Sell |
14,525
-155
| -1% | -$76.1K | 1.82% | 10 |
|
2021
Q4 | $6.81M | Sell |
14,680
-14,557
| -50% | -$6.75M | 1.62% | 23 |
|
2021
Q3 | $11.2M | Hold |
29,237
| – | – | 2.88% | 6 |
|
2021
Q2 | $11.2M | Sell |
29,237
-865
| -3% | -$330K | 2.88% | 6 |
|
2021
Q1 | $10.8M | Buy |
30,102
+27,709
| +1,158% | +$9.95M | 2.95% | 8 |
|
2020
Q4 | $768K | Sell |
2,393
-27,930
| -92% | -$8.96M | 2.93% | 14 |
|
2020
Q3 | $8.14M | Buy |
30,323
+1,201
| +4% | +$323K | 2.56% | 14 |
|
2020
Q2 | $7.66M | Buy |
29,122
+26,729
| +1,117% | +$7.03M | 2.61% | 12 |
|
2020
Q1 | $543K | Sell |
2,393
-28,182
| -92% | -$6.39M | 2.88% | 14 |
|
2019
Q4 | $9.24M | Sell |
30,575
-650
| -2% | -$196K | 2.14% | 8 |
|
2019
Q3 | $7.5M | Sell |
31,225
-825
| -3% | -$198K | 1.85% | 19 |
|
2019
Q2 | $9.05M | Buy |
32,050
+28,750
| +871% | +$8.11M | 2.23% | 10 |
|
2019
Q1 | $947K | Sell |
3,300
-36,450
| -92% | -$10.5M | 4.07% | 6 |
|
2018
Q4 | $10.4M | Sell |
39,750
-3,000
| -7% | -$788K | 2.72% | 7 |
|
2018
Q3 | $11.7M | Sell |
42,750
-300
| -0.7% | -$82.2K | 2.63% | 6 |
|
2018
Q2 | $10.2M | Sell |
43,050
-4,000
| -9% | -$952K | 2.47% | 9 |
|
2018
Q1 | $10.3M | Sell |
47,050
-6,700
| -12% | -$1.47M | 2.46% | 7 |
|
2017
Q4 | $12.1M | Hold |
53,750
| – | – | 2.58% | 6 |
|
2017
Q3 | $10.2M | Sell |
53,750
-9,400
| -15% | -$1.78M | 2.33% | 9 |
|
2017
Q2 | $11.9M | Sell |
63,150
-48,250
| -43% | -$9.08M | 2.74% | 9 |
|
2017
Q1 | $18.4M | Buy |
+111,400
| New | +$18.4M | 2.83% | 11 |
|